End-stage liver disease and liver transplant: Current situation and key issues

Journal of Pediatric Gastroenterology and Nutrition

Volumn 47, Issue 2, 2008, Pages 239-246

  Sokal, E M ^a,j   Goldstein, D ^a   Ciocca, M ^b   Lewindon, P ^c   Ni, Y ^d   Silveira, T ^e   Sibal, A ^f   Dhawan, A ^g   MacK, C ^h   Bucuvalas, J ⁱ  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^f INDRAPRASTHA APOLLO HOSPITAL   (India)

^g KING S COLLEGE HOSPITAL   (United Kingdom)

^h UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

ⁱ CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^j UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOPHOSPHAMIDE; INTERLEUKIN 2 RECEPTOR ANTIBODY; LIVER ENZYME; PREDNISOLONE; PREDNISONE; RAPAMYCIN; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ANEURYSM; BLEEDING; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL PROTOCOL; FOLLOW UP; HEPATOCYTE TRANSPLANTATION; HEPATOPULMONARY SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER DISEASE; LIVER ISCHEMIA; LIVER NECROSIS; LIVER TRANSPLANTATION; METABOLIC DISORDER; PATIENT CARE; PATIENT COMPLIANCE; PATIENT REFERRAL; PORTOENTEROSTOMY; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT ABORTION; REGISTER; RETRANSPLANTATION; REVIEW; SPLEEN ARTERY; STEM CELL TRANSPLANTATION; TREATMENT FAILURE; TREATMENT OUTCOME; VARICOSIS; CHILD; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; LIVER FAILURE; METHODOLOGY; PATIENT SELECTION; POSTOPERATIVE COMPLICATION;

CHILD; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER FAILURE; LIVER TRANSPLANTATION; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; STEM CELL TRANSPLANTATION;

EID: 56049117209     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318181b21c     Document Type: Review

References (29)

1. Reding R, Bourdeaux C, Gras J, et al. The paediatric liver transplantation program at the Universite Catholique de Louvain. Acta Gastroenterol Belg 2004;67:176-8.
2. Tiao GM, Alonso M, Bezerra J, et al. Liver transplantation in children younger than 1 year - the Cincinnati experience. J Pediatr Surg 2005;40:268-73.
3. De Ledinghen V, Le Bail B, Rebouissoux L, et al. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr 2007;45:443-50.
4. Evans HM, Sharif K, Brown RM, et al. Fatal and life threatening rupture of splenic artery aneurysms in children with portal hypertension. Pediatr Transplant 2004;8:192-5.
5. Van Obbergh LJ, Carlier M, De Kock M, et al. Hepatopulmonary syndrome and liver transplantation: a review of the perioperative management of seven paediatric cases. Paediatr Anaesth 1998;8:59-64.
6. Broide E, Farrant P, Reid F, et al. Hepatic artery resistance index can predict early death in children with biliary atresia. Liver Transpl Surg 1997;3:604-10.
7. Ciocca M, Moreira-Silva SF, Alegria S, et al. Hepatitis A as an etiologic agent of acute liver failure in Latin America. Pediatr Infect Dis J 2007;26:711-5.
8. Kelly DA, Sibal A. Liver transplantation in children. Indian Pediatr 2006;43:389-91.
9. Sokal EM. Liver transplantation for inborn errors of liver metabolism. J Inherit Metab Dis 2006;29:426-30.
10. Tiao GM, Bobey N, Allen S, et al. The current management of hepatoblastoma: a combination of chemotherapy, conventional resection, and liver transplantation. J Pediatr 2005;146:204-11.
11. Chardot Ch, Carton M, Spire-Bendelac N, et al. Prognosis of biliary atresia in the era of liver transplantation: French national study from 1986 to 1996. Hepatology 1999;30:606-11.
12. Shneider BL, Brown MB, Haber B, et al. A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr 2006;148:467-74.
13. Evrard V, Otte JB, Sokal E, et al. Impact of surgical and immu-nological parameters in pediatric liver transplantation: a multi-variate analysis in 500 consecutive recipients of primary grafts. Ann Surg 2004;239:272-80.
14. Najimi M, Smets F, Sokal E. Hepatocyte transplantation: current and future developments. Curr Opin Transplant 2007;12:503-8.
15. Smets F, Najimi M, Sokal EM. Cell transplantation in the treatment of liver diseases. Pediatr Transplant 2008;12:6-13.
16. Bourdeaux C, Tri TT, Gras J, et al. PELD score and posttransplant outcome in pediatric liver transplantation: a retrospective study of 100 recipients. Transplantation 2005;79:1273-6.
17. Utterson EC, Shepherd RW, Sokol RJ, et al. Biliary atresia: clinical profiles, risk factors, and outcomes of 755 patients listed for liver transplantation. J Pediatr 2005;147:180-5.
18. Merion RM, Schaubel DE, Dykstra DM, et al. The survival benefit of liver transplantation. Am J Transplant 2005;5:307-13.
19. Tredger JM, Brown NW, Dhawan A. Immunosuppression in pedia-tric solid organ transplantation: opportunities, risks, and management. Pediatr Transplant 2006;10:879-92.
20. Soltys KA, Mazariegos GV, Squires RH, et al. Late graft loss or death in pediatric liver transplantation: an analysis of the SPLIT database. Am J Transplant 2007;7:2165-71.
21. Venkat VL, Nick TG, Wang Y, et al. An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence. Pediatr Transplant 2008;12:67- 72.
22. Shemesh E. Non-adherence to medications following pediatric liver transplantation. Pediatr Transplant 2004;8:600-5.
23. Evans HM, Kelly DA, Mckiernan PJ, et al. Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 2006;43:1109-17.
24. Andries S, Casamayou L, Sempoux C, et al. Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine. Transplantation 2001; 72:267-72.
25. Smets F, Latinne D, Bazin H, et al. Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease. Transplantation 2002;73:1603-10.
26. Gross TG, Bucuvalas JC, Park JR, et al. Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproli-ferative disease in children after solid organ transplantation. J Clin Oncol 2005;23:6481-8.
27. Sokal EM, Hoppenbrouwers K, Vandermeulen C, et al. Recom-binant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults. J Infect Dis 2007; 196:1749-53.
28. Najimi M, Khuu DN, Lysy PA, et al. Adult-derived human liver mesenchymal-like cells as a potential progenitor reservoir of he-patocytes? Cell Transplant 2007;16:717-28.
29. Lysy PA, Campard D, Smets F, et al. Stem cells for liver tissue repair: current knowledge and perspectives. World J Gastroenterol 2008;14:864-75.